Degludec: the new ultra-long insulin analogue

Por Tambascia, Marcos Antonio, Eliaschewitz, Freddy Goldberg
Publicado no Diabetol Metab Syndr (2015)

Depression and alexithymia on weight perception in patients with metabolic syndrome and type 2 diabetes

Por de Oliveira Regina, Maria Cristina, Tambascia, Marcos Antonio
Publicado no Diabetol Metab Syndr (2017)

Influence of gastric emptying on the control of postprandial glycemia: physiology and therapeutic implications

Por Tambascia, Marcos Antonio, Malerbi, Domingos Augusto Cherino, Eliaschewitz, Freddy Goldberg
Publicado no Einstein (Sao Paulo) (2014)

Risk Factors Associated with Benign and Malignant Thyroid Nodules in Autoimmune Thyroid Diseases

Por Lima, Priscila Carneiro Moreira, Moura Neto, Arnaldo, Tambascia, Marcos Antonio, Zantut Wittmann, Denise Engelbrecht
Publicado em 2013

Extremely high doses of radioiodine required for treatment of Graves’ hyperthyroidism: a case report

Por Neto, Arnaldo Moura, Tambascia, Marcos Antonio, Brunetto, Sergio, Ramos, Celso Dario, Zantut-Wittmann, Denise Engelbrecht
Publicado em 2009

Evidence-based clinical use of insulin premixtures

Por Tambascia, Marcos Antônio, Nery, Márcia, Gross, Jorge Luiz, Ermetice, Mariana Narbot, de Oliveira, Carolina Piras
Publicado em 2013

Sagittal Abdominal Diameter as a Surrogate Marker of Insulin Resistance in an Admixtured Population—Brazilian Metabolic Syndrome Study (BRAMS)

Por Vasques, Ana Carolina J., Cassani, Roberta S. L., Forti, Adriana C. e, Vilela, Brunna S., Pareja, José Carlos, Tambascia, Marcos Antonio, Geloneze, Bruno
Publicado no PLoS One (2015)

Homa-adiponectin index as useful surrogate marker in the screeening of insulin resistance

Por Vilela, Brunna Sullara, Vasques, Ana Carolina Junqueira, Cassani, Roberta Soares Lara, e Forti, Adriana Costa, Pareja, José Carlos, Tambascia;, Marcos Antônio, Geloneze, Bruno
Publicado no Diabetol Metab Syndr (2015)

The HOMA-Adiponectin (HOMA-AD) Closely Mirrors the HOMA-IR Index in the Screening of Insulin Resistance in the Brazilian Metabolic Syndrome Study (BRAMS)

Por Vilela, Brunna Sullara, Vasques, Ana Carolina Junqueira, Cassani, Roberta Soares Lara, Forti, Adriana Costa e, Pareja, José Carlos, Tambascia, Marcos Antonio, Geloneze, Bruno
Publicado no PLoS One (2016)

Value of Apoptotic, Antiapoptotic, and Cell Proliferation Markers in the Treatment of Graves' Disease

Por de Vasconcelos, Jessica Castro, Barreto, Icléia Siqueira, Matos, Patrícia Sabino, Maia, Frederico Fernandes Ribeiro, Tambascia, Marcos Antônio, Parisi, Maria Cândida Ribeiro, Zantut-Wittmann, Denise Engelbrecht
Publicado no Int J Endocrinol (2018)

Risk factors for ulceration and amputation in patients with diabetic foot at risk: results form a tertiary care center

Por Fiore, Adriana Russo, Neto, Arnaldo Moura, Daniel, Karla Borges, Minicucci, Walter José, Wittmann, Denise Engelbrecht Zantut, Tambascia, Marcos Antonio, Pavin, Elizabeth João, Parisi, Maria Cândida Ribeiro
Publicado no Diabetol Metab Syndr (2015)